Position in LH
as of Jun 30, 2026
· filed Jul 21, 2026
Position Value
$2,245,320
+$105,771 QoQ
Shares Held
8,019
0.0% QoQ
Ownership
0.010%
of shares outstanding
% of Portfolio
0.17%
of 13F equity value
Holder Rank
#355
of 1,040 holders
Holding Since
Jun 2024
9 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in LH Over Time
Shares Held
Position Value (USD)
Position in Diagnostics & Research
Healthcare · as of Jun 30, 2026LEAVELL INVESTMENT MANAGEMENT, INC. holds $12,070,514 across 8 Diagnostics & Research names. LH ranks #3 (18.6% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | WAT |
Waters Corp /De/
|
9,786 | $3,670,141 | |
| 2 | TMO |
Thermo Fisher Scientific Inc.
|
5,835 | $2,925,435 | |
| 3 | LH |
Labcorp Holdings Inc.
This page
|
8,019 | $2,245,320 | |
| 4 | DHR |
Danaher Corp /De/
|
5,057 | $963,257 | |
| 5 | CRL |
Charles River Laboratories International, Inc.
|
3,804 | $862,709 | |
| 6 | DGX |
Quest Diagnostics Inc
|
3,724 | $789,301 | |
| 7 | ILMN |
Illumina, Inc.
|
2,348 | $412,848 | |
| 8 | A |
Agilent Technologies, Inc.
|
1,517 | $201,503 |
All Filings in LH
Export CSV
9 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $2,245,320 | 8,019 | Shares | Sole | 2026-07-21 | |
| 2026-03-31 | $2,139,549 | 8,019 | Shares | Sole | 2026-05-12 | |
| 2025-12-31 | $2,011,806 | 8,019 | Shares | Sole | 2026-02-09 | |
| 2025-09-30 | $2,301,934 | 8,019 | Shares | Sole | 2025-10-28 | |
| 2025-06-30 | $1,809,743 | 6,894 | Shares | Sole | 2025-07-31 | |
| 2025-03-31 | $1,474,175 | 6,334 | Shares | Sole | 2025-04-30 | |
| 2024-12-31 | $1,354,822 | 5,908 | Shares | Sole | 2025-01-29 | |
| 2024-09-30 | $1,320,319 | 5,908 | Shares | Sole | 2024-11-01 | |
| 2024-06-30 | $1,174,049 | 5,769 | Shares | Sole | 2024-07-17 | |
| No filing history on record for this holder in this stock. | ||||||